The artificial intelligence model predicts patients’ heart disorders and risk of future heart failure using just an ...

The most common cardiovascular killer in maternal medicine is also among the most misdiagnosed. Peripartum cardiomyopathy ...

The FDA has granted approval for the ANDA of Lupin’s Sacubitril and Valsartan Tablets for heart failure patients.

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

Supine hypertension in those without seated hypertension is linked to higher risks for adverse cardiovascular events in ...

Researchers from the UT Southwestern Medical Center have found that lower blood pressure can stop people with type 2 diabetes ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Diabetic cardiomyopathy (DCM) is a specific type of cardiomyopathy that is independent of hypertension and ...

In the first 22 months of a mavacamten REMS program, few patients needed a temporary interruption in treatment for LVEF below 50%.

The blood pressure study could help doctors treating people with diabetes to reduce the risk of "major cardiovascular events" ...

and a pulmonary arterial systolic pressure of 65 mm Hg (normal, <35). How would you further evaluate and treat this patient? Heart failure with preserved ejection fraction is a heterogeneous syndrome.